Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacob U Fog

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
The Journal of Biological Chemistry|August 19, 2005
Identification of intra- and intermolecular disulfide bridges in the multidrug resistance transporter ABCG2Ulla Henriksen, Jacob U Fog, Thomas Litman, et al.
Methods (San Diego, Calif.)|March 11, 2010
Improved microRNA quantification in total RNA from clinical samplesDitte Andreasen, Jacob U Fog, William Biggs, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 6, 2004
Surface targeting of the dopamine transporter involves discrete epitopes in the distal C terminus but does not require canonical PDZ domain interactionsChristian Bjerggaard, Jacob U Fog, Hanne Hastrup, et al.
Biochemistry|August 23, 2007
Membrane mobility and microdomain association of the dopamine transporter studied with fluorescence correlation spectroscopy and fluorescence recovery after photobleachingErika M Adkins, Devadoss J Samuvel, Jacob U Fog, et al.
Diabetes, Obesity & Metabolism|June 10, 2017
A novel GIP analogue, ZP4165, enhances glucagon-like peptide-1-induced body weight loss and improves glycaemic control in rodentsPia K Nørregaard, Maria A Deryabina, Pernille Tofteng Shelton, et al.
Molecular Pharmacology|July 12, 2008
Syntaxin 1A interaction with the dopamine transporter promotes amphetamine-induced dopamine effluxFrancesca Binda, Concetta Dipace, Erica Bowton, et al.
Neuron|August 16, 2006
Calmodulin kinase II interacts with the dopamine transporter C terminus to regulate amphetamine-induced reverse transportJacob U Fog, Habibeh Khoshbouei, Marion Holy, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
The Journal of Biological Chemistry|August 19, 2005
Identification of intra- and intermolecular disulfide bridges in the multidrug resistance transporter ABCG2Ulla Henriksen, Jacob U Fog, Thomas Litman, et al.
Methods (San Diego, Calif.)|March 11, 2010
Improved microRNA quantification in total RNA from clinical samplesDitte Andreasen, Jacob U Fog, William Biggs, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 6, 2004
Surface targeting of the dopamine transporter involves discrete epitopes in the distal C terminus but does not require canonical PDZ domain interactionsChristian Bjerggaard, Jacob U Fog, Hanne Hastrup, et al.
Biochemistry|August 23, 2007
Membrane mobility and microdomain association of the dopamine transporter studied with fluorescence correlation spectroscopy and fluorescence recovery after photobleachingErika M Adkins, Devadoss J Samuvel, Jacob U Fog, et al.
Diabetes, Obesity & Metabolism|June 10, 2017
A novel GIP analogue, ZP4165, enhances glucagon-like peptide-1-induced body weight loss and improves glycaemic control in rodentsPia K Nørregaard, Maria A Deryabina, Pernille Tofteng Shelton, et al.
Molecular Pharmacology|July 12, 2008
Syntaxin 1A interaction with the dopamine transporter promotes amphetamine-induced dopamine effluxFrancesca Binda, Concetta Dipace, Erica Bowton, et al.
Neuron|August 16, 2006
Calmodulin kinase II interacts with the dopamine transporter C terminus to regulate amphetamine-induced reverse transportJacob U Fog, Habibeh Khoshbouei, Marion Holy, et al.
Pageof 1